We’re thrilled to share that Cocoon Bioscience has launched its T4 DNA Ligase, a high-purity (≥95%) and cost-effective enzyme built to meet the growing need for affordable, high-performance molecular biology tools.
By delivering market-leading quality at over 60% lower cost, Cocoon is empowering researchers to do more, discover faster, and push scientific progress further.
At Cleon Capital, we’re proud to back teams like Cocoon that are transforming the biotech landscape with scalable, accessible innovation. 🧬

🔗 Learn more: https://lnkd.in/eXVPFTNH